{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:52:19Z","timestamp":1791233539380,"version":"4.1.0"},"reference-count":93,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Human milk oligosaccharides (HMOs) are the third most abundant solid component in human milk and play crucial roles in shaping the gut microbiome and promoting infant health. Although their functions during infancy are well established, emerging evidence suggests that HMOs exert region-specific effects throughout the gastrointestinal tract, extending their benefits beyond early life. This review summarizes current findings on HMO activity in the oral cavity, stomach, small intestine, and large intestine, focusing on their microbiota-modulating, barrier-enhancing, and immunoregulatory effects. In the oral cavity, HMOs inhibit pathogen adhesion and biofilm formation, maintaining oral homeostasis. In the stomach, fucosylated and sialylated HMOs act as soluble decoy receptors, preventing Helicobacter pylori infection. In the small intestine, HMOs strengthen epithelial integrity, regulate inflammation, and promote nutrient absorption. In the large intestine, they serve as selective prebiotics for beneficial microbes, enhancing short-chain fatty acid production and improving barrier function. Although preclinical and clinical studies demonstrate their safety and efficacy, further research is required to elucidate their mechanisms in adults. Overall, HMOs represent multifunctional bioactive glycans with promising applications for gastrointestinal health across all ages.<\/jats:p>","DOI":"10.3390\/microorganisms14010029","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:35:27Z","timestamp":1766392527000},"page":"29","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gastrointestinal Journey of Human Milk Oligosaccharides: From Breastfeeding Origins to Functional Roles in Adults"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2367-2964","authenticated-orcid":false,"given":"Yosuke","family":"Komatsu","sequence":"first","affiliation":[{"name":"Institute of Health Science, Kirin Holdings Co., Ltd., 2-26-1 Muraoka-Higashi, Fujisawa 251-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Furuichi","sequence":"additional","affiliation":[{"name":"Institute of Health Science, Kirin Holdings Co., Ltd., 2-26-1 Muraoka-Higashi, Fujisawa 251-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9627-3600","authenticated-orcid":false,"given":"Takeshi","family":"Kokubo","sequence":"additional","affiliation":[{"name":"Institute of Health Science, Kirin Holdings Co., Ltd., 2-26-1 Muraoka-Higashi, Fujisawa 251-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2186115","DOI":"10.1080\/19490976.2023.2186115","article-title":"Functional effects of human milk oligosaccharides (HMOs)","volume":"15","author":"Dinleyici","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/jn\/nxaa427","article-title":"Longitudinal changes in human milk oligosaccharides (HMOs) over the course of 24 months of lactation","volume":"151","author":"Plows","year":"2021","journal-title":"J. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wici\u0144ski, M., Sawicka, E., G\u0119balski, J., Kubiak, K., and Malinowski, B. (2020). Human milk oligosaccharides: Health benefits, potential applications in infant formulas, and pharmacology. Nutrients, 12.","DOI":"10.3390\/nu12010266"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/glycob\/cws074","article-title":"Human milk oligosaccharides: Every baby needs a sugar mama","volume":"22","author":"Bode","year":"2012","journal-title":"Glycobiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.earlhumdev.2015.09.001","article-title":"The functional biology of human milk oligosaccharides","volume":"91","author":"Bode","year":"2015","journal-title":"Early Hum. Dev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"25194","DOI":"10.1074\/jbc.M113.484733","article-title":"Lacto-N-biosidase encoded by a novel gene of Bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression","volume":"288","author":"Sakurama","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/glycob\/cwt065","article-title":"Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes","volume":"23","author":"Yu","year":"2013","journal-title":"Glycobiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.3168\/jds.2017-12753","article-title":"Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli","volume":"100","author":"Thongaram","year":"2017","journal-title":"J. Dairy Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/acs.jafc.0c06041","article-title":"Selective utilization of the human milk oligosaccharides 2\u2032-fucosyllactose, 3-fucosyllactose, and difucosyllactose by various probiotic and pathogenic bacteria","volume":"69","author":"Salli","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14112","DOI":"10.1074\/jbc.M207744200","article-title":"Campylobacter jejuni binds intestinal H (O) antigen (Fuc\u03b11,2Gal\u03b21,4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection","volume":"278","author":"Cervantes","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rosa, F., Sharma, A.K., Gurung, M., Casero, D., Matazel, K., Bode, L., Simecka, C., Elolimy, A.A., Tripp, P., and Randolph, C. (2022). Human milk oligosaccharides impact cellular and inflammatory gene expression and immune response. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.907529"},{"key":"ref_12","first-page":"204","article-title":"Human milk oligosaccharides and development of gut microbiota with immune system in newborn infants","volume":"9","author":"Barua","year":"2024","journal-title":"Am. J. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3945\/jn.113.189704","article-title":"Human milk oligosaccharides influence maturation of human intestinal Caco-2Bbe and HT-29 cell lines","volume":"144","author":"Holscher","year":"2014","journal-title":"J. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Natividad, J.M., Rytz, A., Keddani, S., Bergonzelli, G., and Garcia-Rodenas, C.L. (2020). Blends of human milk oligosaccharides confer intestinal epithelial barrier protection in vitro. Nutrients, 12.","DOI":"10.3390\/nu12103047"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1203\/01.pdr.0000200805.45593.17","article-title":"Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris","volume":"59","author":"Coppa","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Vandenplas, Y., Berger, B., Carnielli, V.P., Ksiazyk, J., Lagstr\u00f6m, H., Sanchez Luna, M., Migacheva, N., Mosselmans, J.-M., Picaud, J.-C., and Possner, M. (2018). Human milk oligosaccharides: 2\u2032-fucosyllactose (2\u2032-FL) and lacto-N-neotetraose (LNnT) in infant formula. Nutrients, 10.","DOI":"10.20944\/preprints201807.0416.v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MPG.0000000000001520","article-title":"Effects of infant formula with human milk oligosaccharides on growth and morbidity: A randomized multicenter trial","volume":"64","author":"Puccio","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3945\/jn.116.236919","article-title":"Similar to those who are breastfed, infants fed a formula containing 2\u2032-fucosyllactose have lower inflammatory cytokines in a randomized controlled trial","volume":"146","author":"Goehring","year":"2016","journal-title":"J. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/MPG.0000000000000889","article-title":"Infants fed a lower calorie formula with 2\u2032-FL show growth and 2\u2032-FL uptake like breast-fed infants","volume":"61","author":"Marriage","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Berger, P.K., Ong, M.L., Bode, L., and Belfort, M.B. (2023). Human milk oligosaccharides and infant neurodevelopment: A narrative review. Nutrients, 15.","DOI":"10.3390\/nu15030719"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Fan, Y., McMath, A.L., and Donovan, S.M. (2023). Review on the impact of milk oligosaccharides on the brain and neurocognitive development in early life. Nutrients, 15.","DOI":"10.3390\/nu15173743"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/10408398.2020.1850413","article-title":"Recent advances on 2\u2032-fucosyllactose: Physiological properties, applications, and production approaches","volume":"62","author":"Zhu","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.procbio.2013.10.023","article-title":"Biocatalytic production of 3\u2032-sialyllactose by use of a modified sialidase with superior trans-sialidase activity","volume":"49","author":"Michalak","year":"2014","journal-title":"Process Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"103040","DOI":"10.1016\/j.fbio.2023.103040","article-title":"Engineering Escherichia coli for the efficient biosynthesis of 6\u2032-sialyllactose","volume":"55","author":"Li","year":"2023","journal-title":"Food Biosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000455400","article-title":"Regulatory aspects of human milk oligosaccharides","volume":"88","author":"Salminen","year":"2017","journal-title":"Nestle Nutr. Inst. Workshop Ser."},{"key":"#cr-split#-ref_26.1","unstructured":"EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Bohn, T., Castenmiller, J., De Henauw, S., Hirsch-Ernst, K.I., Maciuk, A., Mangelsdorf, I., McArdle, H.J., and Naska, A. (2023). Safety of 2\u2032-fucosyllactose (2\u2032-FL) produced by a derivative strain (Escherichia coli SGR5) of E. coli W (ATCC 9637) as a novel food pursuant to Regulation"},{"key":"#cr-split#-ref_26.2","unstructured":"(EU) 2015\/2283. EFSA J., 21, e08333."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Bohn, T., Castenmiller, J., De Henauw, S., Hirsch-Ernst, K.I., Maciuk, A., Mangelsdorf, I., McArdle, H.J., and Naska, A. (2023). Safety of 3\u2032-sialyllactose (3\u2032-SL) sodium salt as a novel food (NF) pursuant to Regulation (EU) 2015\/2283. EFSA J., 21, e08224.","DOI":"10.2903\/j.efsa.2023.7995"},{"key":"#cr-split#-ref_28.1","unstructured":"EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Bohn, T., Castenmiller, J., De Henauw, S., Hirsch-Ernst, K.I., Maciuk, A., Mangelsdorf, I., McArdle, H.J., and Naska, A. (2023). Safety of 6\u2032-sialyllactose (6\u2032-SL) sodium salt produced by a derivative strain (Escherichia coli NEO6) of E. coli W (ATCC 9637) as a novel food pursuant to Regulation"},{"key":"#cr-split#-ref_28.2","unstructured":"(EU) 2015\/2283. EFSA J., 21, e08025."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e13271","DOI":"10.1111\/1541-4337.13271","article-title":"Gastrointestinal barrier function, immunity, and neurocognition: The role of human milk oligosaccharide (HMO) supplementation in infant formula","volume":"23","author":"Kassai","year":"2024","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102256","DOI":"10.1016\/j.xcrm.2025.102256","article-title":"A human milk oligosaccharide alters the microbiome, circulating hormones, and metabolites in a randomized controlled trial of older adults","volume":"6","author":"Carter","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Plaza-D\u00edaz, J., Fontana, L., and Gil, A. (2018). Human milk oligosaccharides and immune system development. Nutrients, 10.","DOI":"10.3390\/nu10081038"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pedneo.2020.12.013","article-title":"Recent advance in infant nutrition: Human milk oligosaccharides","volume":"62","author":"Cheng","year":"2021","journal-title":"Pediatr. Neonatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e00094-23","DOI":"10.1128\/mmbr.00094-23","article-title":"Linking human milk oligosaccharide metabolism and early life gut microbiota: Bifidobacteria and beyond","volume":"88","author":"Lordan","year":"2024","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1017\/S0007114520001956","article-title":"Influence of 2\u2032-fucosyllactose and galacto-oligosaccharides on the growth and adhesion of Streptococcus mutans","volume":"124","author":"Salli","year":"2020","journal-title":"Br. J. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/14767058.2020.1730321","article-title":"Development of Streptococcus mutans biofilm in the presence of human colostrum and 3\u2032-sialyllactose","volume":"35","author":"Faria","year":"2022","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/iai.59.5.1605-1613.1991","article-title":"In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuc\u03b11-2Gal\u03b2-bearing complex carbohydrates","volume":"59","author":"Brassart","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"eAO0663","DOI":"10.31744\/einstein_journal\/2025AO0663","article-title":"Effects of 3\u2032-sialyllactose, saliva, and colostrum on Candida albicans biofilms","volume":"23","author":"Faria","year":"2025","journal-title":"Einstein"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3945\/jn.116.230706","article-title":"The human milk oligosaccharide 2\u2032-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal mucosa","volume":"146","author":"Yu","year":"2016","journal-title":"J. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Saha, S., Nair, M.R., Rai, K., Shetty, V., Anees, M.T.M., Shetty, A.K., and D\u2019souza, N. (2025). A novel sugar-free probiotic oral rinse influences oral Candida albicans in children with Down syndrome post complete oral rehabilitation: A pilot randomized clinical trial with 6-month follow-up. Probiotics Antimicrob. Proteins, in press.","DOI":"10.1007\/s12602-025-10511-8"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Turska-Szybka, A., Olczak-Kowalczyk, D., and Twetman, S. (2025). Probiotics, prebiotics, synbiotics, and postbiotics against oral Candida in children: A review of clinical trials. Nutrients, 17.","DOI":"10.3390\/nu17142253"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Shirani, M., Pakzad, R., Haddadi, M.H., Akrami, S., Asadi, A., Kazemian, H., Moradi, M., Kaviar, V.H., Zomorodi, A.R., and Khoshnood, S. (2023). The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: A systematic review and meta-analysis. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08504-5"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1128\/iai.56.11.2896-2906.1988","article-title":"N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: A putative colonization factor antigen","volume":"56","author":"Evans","year":"1988","journal-title":"Infect. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/iai.65.2.750-757.1997","article-title":"Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides","volume":"65","author":"Simon","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0016-5085(99)70282-9","article-title":"Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound","volume":"117","author":"Mysore","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/glycob\/cwi044","article-title":"Interaction of Helicobacter pylori with sialylated carbohydrates: The dependence on different parts of the binding trisaccharide Neu5Ac\u03b13Gal\u03b24GlcNAc","volume":"15","author":"Johansson","year":"2005","journal-title":"Glycobiology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/glycob\/cwi049","article-title":"Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays","volume":"15","author":"Walz","year":"2005","journal-title":"Glycobiology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"25575","DOI":"10.1038\/srep25575","article-title":"Muc5ac gastric mucin glycosylation is shaped by FUT2 activity and functionally impacts Helicobacter pylori binding","volume":"6","author":"Rossez","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3748\/wjg.v10.i14.2063","article-title":"Effects of fucosylated milk of goat and mouse on Helicobacter pylori binding to Lewis b antigen","volume":"10","author":"Xu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1523-5378.2003.00152.x","article-title":"Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3\u2032-sialyllactose sodium salt). A double blind, placebo-controlled clinical study","volume":"8","author":"Parente","year":"2003","journal-title":"Helicobacter"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/MPG.0000000000001274","article-title":"Human milk oligosaccharides influence intestinal epithelial cell maturation in vitro","volume":"64","author":"Holscher","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1900303","DOI":"10.1002\/mnfr.201900303","article-title":"Modulation of intestinal epithelial glycocalyx development by human milk oligosaccharides and non-digestible carbohydrates","volume":"63","author":"Kong","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1900976","DOI":"10.1002\/mnfr.201900976","article-title":"Human milk oligosaccharides differently modulate goblet cells under homeostatic, proinflammatory conditions and ER stress","volume":"64","author":"Cheng","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1800658","DOI":"10.1002\/mnfr.201800658","article-title":"Human milk oligosaccharides increase mucin expression in experimental necrotizing enterocolitis","volume":"63","author":"Wu","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrgastro.2016.119","article-title":"Necrotizing enterocolitis: New insights into pathogenesis and mechanisms","volume":"13","author":"Sodhi","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Nguyen, D.N., Jiang, P., Jacobsen, S., Sangild, P.T., Bendixen, E., and Chatterton, D.E. (2015). Protective effects of transforming growth factor \u03b22 in intestinal epithelial cells by regulation of proteins associated with stress and endotoxin responses. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117608"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41390-020-0852-3","article-title":"The human milk oligosaccharides 2\u2032-fucosyllactose and 6\u2032-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling","volume":"89","author":"Sodhi","year":"2021","journal-title":"Pediatr. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","article-title":"Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases","volume":"4","author":"Sturgeon","year":"2016","journal-title":"Tissue Barriers"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gutjnl-2014-307544","article-title":"The human milk oligosaccharide 2\u2032-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation","volume":"65","author":"He","year":"2016","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jff.2019.05.023","article-title":"Human milk oligosaccharides and its acid hydrolysate LNT2 show immunomodulatory effects via TLRs in a dose-and structure-dependent way","volume":"59","author":"Cheng","year":"2019","journal-title":"J. Funct. Foods"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1900262","DOI":"10.1002\/mnfr.201900262","article-title":"Human milk oligosaccharides protect against necrotizing enterocolitis by inhibiting intestinal damage via increasing the proliferation of crypt cells","volume":"63","author":"Wang","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2000519","DOI":"10.1002\/mnfr.202000519","article-title":"Human milk oligosaccharides protect against necrotizing enterocolitis by activating intestinal cell differentiation","volume":"64","author":"Li","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/jn\/nxz006","article-title":"The combination of 2\u2032-fucosyllactose with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides that enhance influenza vaccine responses is associated with mucosal immune regulation in mice","volume":"149","author":"Xiao","year":"2019","journal-title":"J. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/all.12650","article-title":"Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model","volume":"70","author":"Han","year":"2015","journal-title":"Allergy"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Reverri, E.J., Devitt, A.A., Kajzer, J.A., Baggs, G.E., and Borschel, M.W. (2018). Review of the clinical experiences of feeding infants formula containing the human milk oligosaccharide 2\u2032-fucosyllactose. Nutrients, 10.","DOI":"10.3390\/nu10101346"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/gutjnl-2023-330301","article-title":"Human milk oligosaccharide 2\u2032-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and faecal proteome profiles in mice","volume":"73","author":"Paone","year":"2024","journal-title":"Gut"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Azagra-Boronat, I., Massot-Cladera, M., Mayneris-Perxachs, J., Knipping, K., Van\u2019t Land, B., Tims, S., Stahl, B., Garssen, J., Franch, \u00c0., and Castell, M. (2019). Immunomodulatory and prebiotic effects of 2\u2032-fucosyllactose in suckling rats. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01773"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e00648-24","DOI":"10.1128\/aem.00648-24","article-title":"Selective human milk oligosaccharide utilization by members of the Bifidobacterium pseudocatenulatum taxon","volume":"90","author":"Bottacini","year":"2024","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Onodera, H., Sato, Y., Komatsu, Y., Yamashita, M., Watanabe, Y., and Kokubo, T. (2025). HMOs induce butyrate production of Faecalibacterium prausnitzii via cross-feeding by Bifidobacterium bifidum with different mechanisms for HMO types. Microorganisms, 13.","DOI":"10.3390\/microorganisms13071705"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Verhoeckx, K., Cotter, P., L\u00f3pez-Exp\u00f3sito, I., Kleiveland, C., Lea, T., Mackie, A., Requena, T., Swiatecka, D., and Wichers, H. (2015). The simulator of the human intestinal microbial ecosystem (SHIME\u00ae). The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models, Springer.","DOI":"10.1007\/978-3-319-16104-4"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Sato, Y., Kanayama, M., Nakajima, S., Hishida, Y., and Watanabe, Y. (2024). Sialyllactose enhances the short-chain fatty acid production and barrier function of gut epithelial cells via nonbifidogenic modification of the fecal microbiome in human adults. Microorganisms, 12.","DOI":"10.3390\/microorganisms12020252"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3746\/pnf.2025.30.4.331","article-title":"Comparative analysis of fucosyllactose-induced changes in adult gut microbiota and short-chain fatty acid production using the simulator of human intestinal microbial ecosystem model","volume":"30","author":"Sato","year":"2025","journal-title":"Prev. Nutr. Food Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"\u0160uligoj, T., Vigsn\u00e6s, L.K., Van den Abbeele, P., Apostolou, A., Karalis, K., Savva, G.M., McConnell, B., and Juge, N. (2020). Effects of human milk oligosaccharides on the adult gut microbiota and barrier function. Nutrients, 12.","DOI":"10.3390\/nu12092808"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Pham, V.T., Steinert, R.E., Duysburgh, C., Ghyselinck, J., Marzorati, M., and Dekker, P.J. (2023). In vitro effect of enzymes and human milk oligosaccharides on FODMAP digestion and fecal microbiota composition. Nutrients, 15.","DOI":"10.3390\/nu15071637"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1017\/S0007114516003354","article-title":"Oral supplementation of healthy adults with 2\u2032-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota","volume":"116","author":"Elison","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e13920","DOI":"10.1111\/nmo.13920","article-title":"Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double-blind, placebo-controlled study","volume":"32","author":"Iribarren","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"14308","DOI":"10.1038\/s41598-023-41040-5","article-title":"Human milk oligosaccharides modulate the intestinal microbiome of healthy adults","volume":"13","author":"Jacobs","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Yao, Q., Fan, L., Zheng, N., Blecker, C., Delcenserie, V., Li, H., and Wang, J. (2022). 2\u2032-fucosyllactose ameliorates inflammatory bowel disease by modulating gut microbiota and promoting MUC2 expression. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.822020"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Kim, Y.J., Kim, H.H., Shin, C.S., Yoon, J.W., Jeon, S.M., Song, Y.H., Kim, K.-Y., and Kim, K. (2023). 2\u2032-Fucosyllactose and 3-fucosyllactose alleviate interleukin-6-induced barrier dysfunction and dextran sodium sulfate-induced colitis by improving intestinal barrier function and modulating the intestinal microbiome. Nutrients, 15.","DOI":"10.3390\/nu15081845"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Grabinger, T., Glaus Garzon, J.F., Hausmann, M., Geirnaert, A., Lacroix, C., and Hennet, T. (2019). Alleviation of intestinal inflammation by oral supplementation with 2-fucosyllactose in mice. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01385"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"G23","DOI":"10.1152\/ajpgi.00233.2022","article-title":"Human milk oligosaccharides reduce necrotizing enterocolitis-induced neuroinflammation and cognitive impairment in mice","volume":"325","author":"Sodhi","year":"2023","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20101098","article-title":"Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization","volume":"207","author":"Fuhrer","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e00276","DOI":"10.14309\/ctg.0000000000000276","article-title":"Human milk oligosaccharides support normal bowel function and improve symptoms of irritable bowel syndrome: A multicenter, open-label trial","volume":"11","author":"Palsson","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ryan, J.J., Monteagudo-Mera, A., Contractor, N., and Gibson, G.R. (2021). Impact of 2\u2032-fucosyllactose on gut microbiota composition in adults with chronic gastrointestinal conditions: Batch culture fermentation model and pilot clinical trial findings. Nutrients, 13.","DOI":"10.3390\/nu13030938"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ajcnut.2023.08.016","article-title":"Inulin-type fructans and 2\u2032-fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): The EFFICAD trial, a randomized, controlled trial","volume":"118","author":"Jackson","year":"2023","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Yao, Q., Li, H., Gao, Y., Zheng, N., Delcenserie, V., and Wang, J. (2023). The milk active ingredient, 2\u2032-fucosyllactose, inhibits inflammation and promotes MUC2 secretion in LS174T goblet cells in vitro. Foods, 12.","DOI":"10.3390\/foods12010186"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Natividad, J.M., Marsaux, B., Rodenas, C.L.G., Rytz, A., Vandevijver, G., Marzorati, M., Abbeele, P.V.D., Calatayud, M., and Rochat, F. (2022). Human milk oligosaccharides and lactose differentially affect infant gut microbiota and intestinal barrier in vitro. Nutrients, 14.","DOI":"10.3390\/nu14122546"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Azagra-Boronat, I., Massot-Cladera, M., Knipping, K., Van\u2019t Land, B., Stahl, B., Garssen, J., Rodr\u00edguez-Lagunas, M.J., Franch, \u00c0., Castell, M., and P\u00e9rez-Cano, F.J. (2018). Supplementation with 2\u2032-FL and scGOS\/lcFOS ameliorates rotavirus-induced diarrhea in suckling rats. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00372"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e70418","DOI":"10.1002\/fsn3.70418","article-title":"2\u2032-Fucosyllactose modulates the intestinal immune response to gut microbiota and buffers experimental colitis in mice: An integrating investigation of colonic proteomics and gut microbiota analysis","volume":"13","author":"Dong","year":"2025","journal-title":"Food Sci. Nutr."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/1\/29\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:49:44Z","timestamp":1766393384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/1\/29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["microorganisms14010029"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14010029","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}